CHAMPIONS ONCOLOGY, INC. Stockholders' Equity Attributable to Noncontrolling Interest
CHAMPIONS ONCOLOGY, INC. (CSBR) had Stockholders' Equity Attributable to Noncontrolling Interest of $567.00 thousand as of 2026-07-31, per its 10-Q filed 2026-09-11.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:MinorityInterest · last filed 2026-09-11
- 2026-07-31: Stockholders' Equity Attributable to Noncontrolling Interest $567.00K.
- 2026-04-30: Stockholders' Equity Attributable to Noncontrolling Interest $129.00K.
- 2026-01-31: Stockholders' Equity Attributable to Noncontrolling Interest $95.00K.
- 2025-10-31: Stockholders' Equity Attributable to Noncontrolling Interest $61.00K.
| Period end | Stockholders' Equity Attributable to Noncontrolling Interest |
|---|---|
| 2026-07-31 | $567.00K 10-Q · filed 2026-09-11 |
| 2026-04-30 | $129.00K 10-Q · filed 2026-09-11 |
| 2026-01-31 | $95.00K 10-Q · filed 2026-03-12 |
| 2025-10-31 | $61.00K 10-Q · filed 2025-12-15 |
| 2025-07-31 | $30.00K 10-Q · filed 2025-09-15 |
| 2025-04-30 | $0.00 10-K · filed 2026-07-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |